 | • レポートコード：QYR2104Z3052 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品、ヘルスケア |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、免疫蛍光アッセイのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗体、キット・試薬、標識色素、種タイプ）、用途別市場規模（臨床研究、実験室診断）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・免疫蛍光アッセイの市場動向 ・企業の競争状況、市場シェア ・免疫蛍光アッセイの種類別市場規模（抗体、キット・試薬、標識色素、種タイプ） ・免疫蛍光アッセイの用途別市場規模（臨床研究、実験室診断） ・免疫蛍光アッセイの北米市場規模2016-2027（アメリカ、カナダ） ・免疫蛍光アッセイのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・免疫蛍光アッセイのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・免疫蛍光アッセイの中南米市場規模2016-2027（メキシコ、ブラジル） ・免疫蛍光アッセイの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Thermo Fisher (US)、Inova Diagnostics (US)、Bio-Rad (US)、Abcam (UK)、PerkinELmer (US)、Merck Millipore (US)、Cell Signaling Technology (US)、MEDIPAN GMBH (Germany)、Sino Biological (China)、Danaher (US)、Vector Laboratories (US)） ・結論 |
Immunofluorescence is the specific antigen and antibody reaction where the antibodies are labeled with a fluorescent dye and the antigen-antibody complex is visualized using fluorescent (UV) microscope. Some of the commonly used fluorochromes include Acridine Orange, Lissamine, Rhodamine, and Calcofluor white. Various factors determine the type of immunofluorescence assay used such as time consumed, cost, complexity, flexibility, sensitivity, cross reactivity and many others. It is used in all disciplines of biology including medicine for diagnostics and research. Immunofluorescence assays are used to detect specific proteins in cells that may be in specimen, in culture, in tissues, on microbeads and microarrays, etc.
Market Analysis and Insights: Global Immunofluorescence Assays Market
The global Immunofluorescence Assays market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Immunofluorescence Assays market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Immunofluorescence Assays market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Immunofluorescence Assays market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Immunofluorescence Assays market.
Global Immunofluorescence Assays Scope and Market Size
Immunofluorescence Assays market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Immunofluorescence Assays market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Antibodies
Kits and reagents
Labeling dyes
Species type
Segment by Application
Clinical Research
Laboratory Diagnostics
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Thermo Fisher (US)
Inova Diagnostics (US)
Bio-Rad (US)
Abcam (UK)
PerkinELmer (US)
Merck Millipore (US)
Cell Signaling Technology (US)
MEDIPAN GMBH (Germany)
Sino Biological (China)
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immunofluorescence Assays Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Antibodies
1.2.3 Kits and reagents
1.2.4 Labeling dyes
1.2.5 Species type
1.3 Market by Application
1.3.1 Global Immunofluorescence Assays Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinical Research
1.3.3 Laboratory Diagnostics
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Immunofluorescence Assays Market Perspective (2016-2027)
2.2 Immunofluorescence Assays Growth Trends by Regions
2.2.1 Immunofluorescence Assays Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Immunofluorescence Assays Historic Market Share by Regions (2016-2021)
2.2.3 Immunofluorescence Assays Forecasted Market Size by Regions (2022-2027)
2.3 Immunofluorescence Assays Industry Dynamic
2.3.1 Immunofluorescence Assays Market Trends
2.3.2 Immunofluorescence Assays Market Drivers
2.3.3 Immunofluorescence Assays Market Challenges
2.3.4 Immunofluorescence Assays Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Immunofluorescence Assays Players by Revenue
3.1.1 Global Top Immunofluorescence Assays Players by Revenue (2016-2021)
3.1.2 Global Immunofluorescence Assays Revenue Market Share by Players (2016-2021)
3.2 Global Immunofluorescence Assays Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Immunofluorescence Assays Revenue
3.4 Global Immunofluorescence Assays Market Concentration Ratio
3.4.1 Global Immunofluorescence Assays Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immunofluorescence Assays Revenue in 2020
3.5 Immunofluorescence Assays Key Players Head office and Area Served
3.6 Key Players Immunofluorescence Assays Product Solution and Service
3.7 Date of Enter into Immunofluorescence Assays Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Immunofluorescence Assays Breakdown Data by Type
4.1 Global Immunofluorescence Assays Historic Market Size by Type (2016-2021)
4.2 Global Immunofluorescence Assays Forecasted Market Size by Type (2022-2027)
5 Immunofluorescence Assays Breakdown Data by Application
5.1 Global Immunofluorescence Assays Historic Market Size by Application (2016-2021)
5.2 Global Immunofluorescence Assays Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Immunofluorescence Assays Market Size (2016-2027)
6.2 North America Immunofluorescence Assays Market Size by Type
6.2.1 North America Immunofluorescence Assays Market Size by Type (2016-2021)
6.2.2 North America Immunofluorescence Assays Market Size by Type (2022-2027)
6.2.3 North America Immunofluorescence Assays Market Size by Type (2016-2027)
6.3 North America Immunofluorescence Assays Market Size by Application
6.3.1 North America Immunofluorescence Assays Market Size by Application (2016-2021)
6.3.2 North America Immunofluorescence Assays Market Size by Application (2022-2027)
6.3.3 North America Immunofluorescence Assays Market Size by Application (2016-2027)
6.4 North America Immunofluorescence Assays Market Size by Country
6.4.1 North America Immunofluorescence Assays Market Size by Country (2016-2021)
6.4.2 North America Immunofluorescence Assays Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Immunofluorescence Assays Market Size (2016-2027)
7.2 Europe Immunofluorescence Assays Market Size by Type
7.2.1 Europe Immunofluorescence Assays Market Size by Type (2016-2021)
7.2.2 Europe Immunofluorescence Assays Market Size by Type (2022-2027)
7.2.3 Europe Immunofluorescence Assays Market Size by Type (2016-2027)
7.3 Europe Immunofluorescence Assays Market Size by Application
7.3.1 Europe Immunofluorescence Assays Market Size by Application (2016-2021)
7.3.2 Europe Immunofluorescence Assays Market Size by Application (2022-2027)
7.3.3 Europe Immunofluorescence Assays Market Size by Application (2016-2027)
7.4 Europe Immunofluorescence Assays Market Size by Country
7.4.1 Europe Immunofluorescence Assays Market Size by Country (2016-2021)
7.4.2 Europe Immunofluorescence Assays Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Immunofluorescence Assays Market Size (2016-2027)
8.2 Asia-Pacific Immunofluorescence Assays Market Size by Type
8.2.1 Asia-Pacific Immunofluorescence Assays Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Immunofluorescence Assays Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Immunofluorescence Assays Market Size by Type (2016-2027)
8.3 Asia-Pacific Immunofluorescence Assays Market Size by Application
8.3.1 Asia-Pacific Immunofluorescence Assays Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Immunofluorescence Assays Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Immunofluorescence Assays Market Size by Application (2016-2027)
8.4 Asia-Pacific Immunofluorescence Assays Market Size by Region
8.4.1 Asia-Pacific Immunofluorescence Assays Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Immunofluorescence Assays Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Immunofluorescence Assays Market Size (2016-2027)
9.2 Latin America Immunofluorescence Assays Market Size by Type
9.2.1 Latin America Immunofluorescence Assays Market Size by Type (2016-2021)
9.2.2 Latin America Immunofluorescence Assays Market Size by Type (2022-2027)
9.2.3 Latin America Immunofluorescence Assays Market Size by Type (2016-2027)
9.3 Latin America Immunofluorescence Assays Market Size by Application
9.3.1 Latin America Immunofluorescence Assays Market Size by Application (2016-2021)
9.3.2 Latin America Immunofluorescence Assays Market Size by Application (2022-2027)
9.3.3 Latin America Immunofluorescence Assays Market Size by Application (2016-2027)
9.4 Latin America Immunofluorescence Assays Market Size by Country
9.4.1 Latin America Immunofluorescence Assays Market Size by Country (2016-2021)
9.4.2 Latin America Immunofluorescence Assays Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Immunofluorescence Assays Market Size (2016-2027)
10.2 Middle East & Africa Immunofluorescence Assays Market Size by Type
10.2.1 Middle East & Africa Immunofluorescence Assays Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Immunofluorescence Assays Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Immunofluorescence Assays Market Size by Type (2016-2027)
10.3 Middle East & Africa Immunofluorescence Assays Market Size by Application
10.3.1 Middle East & Africa Immunofluorescence Assays Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Immunofluorescence Assays Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Immunofluorescence Assays Market Size by Application (2016-2027)
10.4 Middle East & Africa Immunofluorescence Assays Market Size by Country
10.4.1 Middle East & Africa Immunofluorescence Assays Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Immunofluorescence Assays Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Thermo Fisher (US)
11.1.1 Thermo Fisher (US) Company Details
11.1.2 Thermo Fisher (US) Business Overview
11.1.3 Thermo Fisher (US) Immunofluorescence Assays Introduction
11.1.4 Thermo Fisher (US) Revenue in Immunofluorescence Assays Business (2016-2021)
11.1.5 Thermo Fisher (US) Recent Development
11.2 Inova Diagnostics (US)
11.2.1 Inova Diagnostics (US) Company Details
11.2.2 Inova Diagnostics (US) Business Overview
11.2.3 Inova Diagnostics (US) Immunofluorescence Assays Introduction
11.2.4 Inova Diagnostics (US) Revenue in Immunofluorescence Assays Business (2016-2021)
11.2.5 Inova Diagnostics (US) Recent Development
11.3 Bio-Rad (US)
11.3.1 Bio-Rad (US) Company Details
11.3.2 Bio-Rad (US) Business Overview
11.3.3 Bio-Rad (US) Immunofluorescence Assays Introduction
11.3.4 Bio-Rad (US) Revenue in Immunofluorescence Assays Business (2016-2021)
11.3.5 Bio-Rad (US) Recent Development
11.4 Abcam (UK)
11.4.1 Abcam (UK) Company Details
11.4.2 Abcam (UK) Business Overview
11.4.3 Abcam (UK) Immunofluorescence Assays Introduction
11.4.4 Abcam (UK) Revenue in Immunofluorescence Assays Business (2016-2021)
11.4.5 Abcam (UK) Recent Development
11.5 PerkinELmer (US)
11.5.1 PerkinELmer (US) Company Details
11.5.2 PerkinELmer (US) Business Overview
11.5.3 PerkinELmer (US) Immunofluorescence Assays Introduction
11.5.4 PerkinELmer (US) Revenue in Immunofluorescence Assays Business (2016-2021)
11.5.5 PerkinELmer (US) Recent Development
11.6 Merck Millipore (US)
11.6.1 Merck Millipore (US) Company Details
11.6.2 Merck Millipore (US) Business Overview
11.6.3 Merck Millipore (US) Immunofluorescence Assays Introduction
11.6.4 Merck Millipore (US) Revenue in Immunofluorescence Assays Business (2016-2021)
11.6.5 Merck Millipore (US) Recent Development
11.7 Cell Signaling Technology (US)
11.7.1 Cell Signaling Technology (US) Company Details
11.7.2 Cell Signaling Technology (US) Business Overview
11.7.3 Cell Signaling Technology (US) Immunofluorescence Assays Introduction
11.7.4 Cell Signaling Technology (US) Revenue in Immunofluorescence Assays Business (2016-2021)
11.7.5 Cell Signaling Technology (US) Recent Development
11.8 MEDIPAN GMBH (Germany)
11.8.1 MEDIPAN GMBH (Germany) Company Details
11.8.2 MEDIPAN GMBH (Germany) Business Overview
11.8.3 MEDIPAN GMBH (Germany) Immunofluorescence Assays Introduction
11.8.4 MEDIPAN GMBH (Germany) Revenue in Immunofluorescence Assays Business (2016-2021)
11.8.5 MEDIPAN GMBH (Germany) Recent Development
11.9 Sino Biological (China)
11.9.1 Sino Biological (China) Company Details
11.9.2 Sino Biological (China) Business Overview
11.9.3 Sino Biological (China) Immunofluorescence Assays Introduction
11.9.4 Sino Biological (China) Revenue in Immunofluorescence Assays Business (2016-2021)
11.9.5 Sino Biological (China) Recent Development
11.10 Danaher (US)
11.10.1 Danaher (US) Company Details
11.10.2 Danaher (US) Business Overview
11.10.3 Danaher (US) Immunofluorescence Assays Introduction
11.10.4 Danaher (US) Revenue in Immunofluorescence Assays Business (2016-2021)
11.10.5 Danaher (US) Recent Development
11.11 Vector Laboratories (US)
11.11.1 Vector Laboratories (US) Company Details
11.11.2 Vector Laboratories (US) Business Overview
11.11.3 Vector Laboratories (US) Immunofluorescence Assays Introduction
11.11.4 Vector Laboratories (US) Revenue in Immunofluorescence Assays Business (2016-2021)
11.11.5 Vector Laboratories (US) Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Immunofluorescence Assays Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Antibodies
Table 3. Key Players of Kits and reagents
Table 4. Key Players of Labeling dyes
Table 5. Key Players of Species type
Table 6. Global Immunofluorescence Assays Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Immunofluorescence Assays Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Immunofluorescence Assays Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Immunofluorescence Assays Market Share by Regions (2016-2021)
Table 10. Global Immunofluorescence Assays Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Immunofluorescence Assays Market Share by Regions (2022-2027)
Table 12. Immunofluorescence Assays Market Trends
Table 13. Immunofluorescence Assays Market Drivers
Table 14. Immunofluorescence Assays Market Challenges
Table 15. Immunofluorescence Assays Market Restraints
Table 16. Global Immunofluorescence Assays Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Immunofluorescence Assays Market Share by Players (2016-2021)
Table 18. Global Top Immunofluorescence Assays Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immunofluorescence Assays as of 2020)
Table 19. Ranking of Global Top Immunofluorescence Assays Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Immunofluorescence Assays Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Immunofluorescence Assays Product Solution and Service
Table 23. Date of Enter into Immunofluorescence Assays Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Immunofluorescence Assays Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Immunofluorescence Assays Revenue Market Share by Type (2016-2021)
Table 27. Global Immunofluorescence Assays Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Immunofluorescence Assays Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Immunofluorescence Assays Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Immunofluorescence Assays Revenue Market Share by Application (2016-2021)
Table 31. Global Immunofluorescence Assays Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Immunofluorescence Assays Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Immunofluorescence Assays Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Immunofluorescence Assays Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Immunofluorescence Assays Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Immunofluorescence Assays Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Immunofluorescence Assays Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Immunofluorescence Assays Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Immunofluorescence Assays Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Immunofluorescence Assays Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Immunofluorescence Assays Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Immunofluorescence Assays Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Immunofluorescence Assays Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Immunofluorescence Assays Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Immunofluorescence Assays Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Immunofluorescence Assays Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Immunofluorescence Assays Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Immunofluorescence Assays Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Immunofluorescence Assays Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Immunofluorescence Assays Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Immunofluorescence Assays Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Immunofluorescence Assays Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Immunofluorescence Assays Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Immunofluorescence Assays Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Immunofluorescence Assays Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Immunofluorescence Assays Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Immunofluorescence Assays Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Immunofluorescence Assays Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Immunofluorescence Assays Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Immunofluorescence Assays Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Immunofluorescence Assays Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Immunofluorescence Assays Market Size by Country (2022-2027) & (US$ Million)
Table 63. Thermo Fisher (US) Company Details
Table 64. Thermo Fisher (US) Business Overview
Table 65. Thermo Fisher (US) Immunofluorescence Assays Product
Table 66. Thermo Fisher (US) Revenue in Immunofluorescence Assays Business (2016-2021) & (US$ Million)
Table 67. Thermo Fisher (US) Recent Development
Table 68. Inova Diagnostics (US) Company Details
Table 69. Inova Diagnostics (US) Business Overview
Table 70. Inova Diagnostics (US) Immunofluorescence Assays Product
Table 71. Inova Diagnostics (US) Revenue in Immunofluorescence Assays Business (2016-2021) & (US$ Million)
Table 72. Inova Diagnostics (US) Recent Development
Table 73. Bio-Rad (US) Company Details
Table 74. Bio-Rad (US) Business Overview
Table 75. Bio-Rad (US) Immunofluorescence Assays Product
Table 76. Bio-Rad (US) Revenue in Immunofluorescence Assays Business (2016-2021) & (US$ Million)
Table 77. Bio-Rad (US) Recent Development
Table 78. Abcam (UK) Company Details
Table 79. Abcam (UK) Business Overview
Table 80. Abcam (UK) Immunofluorescence Assays Product
Table 81. Abcam (UK) Revenue in Immunofluorescence Assays Business (2016-2021) & (US$ Million)
Table 82. Abcam (UK) Recent Development
Table 83. PerkinELmer (US) Company Details
Table 84. PerkinELmer (US) Business Overview
Table 85. PerkinELmer (US) Immunofluorescence Assays Product
Table 86. PerkinELmer (US) Revenue in Immunofluorescence Assays Business (2016-2021) & (US$ Million)
Table 87. PerkinELmer (US) Recent Development
Table 88. Merck Millipore (US) Company Details
Table 89. Merck Millipore (US) Business Overview
Table 90. Merck Millipore (US) Immunofluorescence Assays Product
Table 91. Merck Millipore (US) Revenue in Immunofluorescence Assays Business (2016-2021) & (US$ Million)
Table 92. Merck Millipore (US) Recent Development
Table 93. Cell Signaling Technology (US) Company Details
Table 94. Cell Signaling Technology (US) Business Overview
Table 95. Cell Signaling Technology (US) Immunofluorescence Assays Product
Table 96. Cell Signaling Technology (US) Revenue in Immunofluorescence Assays Business (2016-2021) & (US$ Million)
Table 97. Cell Signaling Technology (US) Recent Development
Table 98. MEDIPAN GMBH (Germany) Company Details
Table 99. MEDIPAN GMBH (Germany) Business Overview
Table 100. MEDIPAN GMBH (Germany) Revenue in Immunofluorescence Assays Business (2016-2021) & (US$ Million)
Table 101. MEDIPAN GMBH (Germany) Recent Development
Table 102. Sino Biological (China) Company Details
Table 103. Sino Biological (China) Business Overview
Table 104. Sino Biological (China) Immunofluorescence Assays Product
Table 105. Sino Biological (China) Revenue in Immunofluorescence Assays Business (2016-2021) & (US$ Million)
Table 106. Sino Biological (China) Recent Development
Table 107. Danaher (US) Company Details
Table 108. Danaher (US) Business Overview
Table 109. Danaher (US) Immunofluorescence Assays Product
Table 110. Danaher (US) Revenue in Immunofluorescence Assays Business (2016-2021) & (US$ Million)
Table 111. Danaher (US) Recent Development
Table 112. Vector Laboratories (US) Company Details
Table 113. Vector Laboratories (US) Business Overview
Table 114. Vector Laboratories (US) Immunofluorescence Assays Product
Table 115. Vector Laboratories (US) Revenue in Immunofluorescence Assays Business (2016-2021) & (US$ Million)
Table 116. Vector Laboratories (US) Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Immunofluorescence Assays Market Share by Type: 2020 VS 2027
Figure 2. Antibodies Features
Figure 3. Kits and reagents Features
Figure 4. Labeling dyes Features
Figure 5. Species type Features
Figure 6. Global Immunofluorescence Assays Market Share by Application: 2020 VS 2027
Figure 7. Clinical Research Case Studies
Figure 8. Laboratory Diagnostics Case Studies
Figure 9. Immunofluorescence Assays Report Years Considered
Figure 10. Global Immunofluorescence Assays Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Immunofluorescence Assays Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Immunofluorescence Assays Market Share by Regions: 2020 VS 2027
Figure 13. Global Immunofluorescence Assays Market Share by Regions (2022-2027)
Figure 14. Global Immunofluorescence Assays Market Share by Players in 2020
Figure 15. Global Top Immunofluorescence Assays Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immunofluorescence Assays as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Immunofluorescence Assays Revenue in 2020
Figure 17. Global Immunofluorescence Assays Revenue Market Share by Type (2016-2021)
Figure 18. Global Immunofluorescence Assays Revenue Market Share by Type (2022-2027)
Figure 19. North America Immunofluorescence Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Immunofluorescence Assays Market Share by Type (2016-2027)
Figure 21. North America Immunofluorescence Assays Market Share by Application (2016-2027)
Figure 22. North America Immunofluorescence Assays Market Share by Country (2016-2027)
Figure 23. United States Immunofluorescence Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Immunofluorescence Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Immunofluorescence Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Immunofluorescence Assays Market Share by Type (2016-2027)
Figure 27. Europe Immunofluorescence Assays Market Share by Application (2016-2027)
Figure 28. Europe Immunofluorescence Assays Market Share by Country (2016-2027)
Figure 29. Germany Immunofluorescence Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Immunofluorescence Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Immunofluorescence Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Immunofluorescence Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Immunofluorescence Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Immunofluorescence Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Immunofluorescence Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Immunofluorescence Assays Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Immunofluorescence Assays Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Immunofluorescence Assays Market Share by Region (2016-2027)
Figure 39. China Immunofluorescence Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Immunofluorescence Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Immunofluorescence Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Immunofluorescence Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Immunofluorescence Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Immunofluorescence Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Immunofluorescence Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Immunofluorescence Assays Market Share by Type (2016-2027)
Figure 47. Latin America Immunofluorescence Assays Market Share by Application (2016-2027)
Figure 48. Latin America Immunofluorescence Assays Market Share by Country (2016-2027)
Figure 49. Mexico Immunofluorescence Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Immunofluorescence Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Immunofluorescence Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Immunofluorescence Assays Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Immunofluorescence Assays Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Immunofluorescence Assays Market Share by Country (2016-2027)
Figure 55. Turkey Immunofluorescence Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Immunofluorescence Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Immunofluorescence Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Thermo Fisher (US) Revenue Growth Rate in Immunofluorescence Assays Business (2016-2021)
Figure 59. Inova Diagnostics (US) Revenue Growth Rate in Immunofluorescence Assays Business (2016-2021)
Figure 60. Bio-Rad (US) Revenue Growth Rate in Immunofluorescence Assays Business (2016-2021)
Figure 61. Abcam (UK) Revenue Growth Rate in Immunofluorescence Assays Business (2016-2021)
Figure 62. PerkinELmer (US) Revenue Growth Rate in Immunofluorescence Assays Business (2016-2021)
Figure 63. Merck Millipore (US) Revenue Growth Rate in Immunofluorescence Assays Business (2016-2021)
Figure 64. Cell Signaling Technology (US) Revenue Growth Rate in Immunofluorescence Assays Business (2016-2021)
Figure 65. MEDIPAN GMBH (Germany) Revenue Growth Rate in Immunofluorescence Assays Business (2016-2021)
Figure 66. Sino Biological (China) Revenue Growth Rate in Immunofluorescence Assays Business (2016-2021)
Figure 67. Danaher (US) Revenue Growth Rate in Immunofluorescence Assays Business (2016-2021)
Figure 68. Vector Laboratories (US) Revenue Growth Rate in Immunofluorescence Assays Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
世界の神経科学抗体＆アッセイ市場規模・現状・予測（2021年-2027年） The demand for Neuroscience Antibodies and Assays is increasing, due to the rising incidence of neurological diseases, increasing investments in neuroscience research, and growth in the pharmaceutical and biotechnology industries. Market Analysis and Insights: Global Neuroscience Antibodies and Assa…- 世界の神経科学抗体＆アッセイ市場規模・現状・予測（2021年-2027年） The demand for Neuroscience Antibodies and Assays is increasing, due to the rising incidence of neurological diseases, increasing investments in neuroscience research, and growth in the pharmaceutical and biotechnology industries. Market Analysis and Insights: Global Neuroscience Antibodies and Assa…
- 世界の生物学的マルチプレックスアッセイ市場規模・現状・予測（2021年-2027年） Multiplex assays enables the simultaneous detection of multiple analytes in a single run/cycle of the assay. By geography, North America is expected to account for the largest share of the multiplex assays market in 2018, followed by Europe. Market Analysis and Insights: Global Biological Multiplex …
- 世界の高密度マルチプレックス診断検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global High-density Multiplexed Diagnostic Assays Market The global High-density Multiplexed Diagnostic Assays market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in an…
- 世界の高密度マルチプレックス診断検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global High-density Multiplexed Diagnostic Assays Market The global High-density Multiplexed Diagnostic Assays market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in an…